Pathogenic Keratinocyte States and Fibroblast Niches Define the Tissue Microenvironment in Severe Hidradenitis Suppurativa

This study utilizes single-cell RNA-sequencing and spatial transcriptomics to define the cellular architecture of severe hidradenitis suppurativa, revealing a pathogenic S100+ keratinocyte state and spatially distinct fibroblast niches that coordinate with immune cells to shape the disease's inflammatory microenvironment.

The Gist

Imagine your skin is a bustling, well-organized city. Under normal circumstances, the epidermis (the outer layer) is like the residential district where people (keratinocytes) live, work, and follow a strict schedule: they are born, grow up, and eventually move to the surface to shed off like old leaves. The dermis (the layer underneath) is the industrial and infrastructure zone, managed by fibroblasts (the city planners and construction crews) who keep the buildings standing and the roads smooth.

In a healthy city, these two zones talk to each other politely, and the immune system (the police and emergency services) only shows up when there's a real emergency.

Now, imagine this city is suffering from Hidradenitis Suppurativa (HS). This is a chronic, painful condition where the city breaks down. Instead of just having a few bad neighborhoods, the whole infrastructure is in chaos. Painful tunnels form underground, abscesses (like toxic waste dumps) appear, and the police are constantly overwhelmed.

This new research paper acts like a high-tech "city planner's report" that uses advanced mapping tools to figure out exactly why the city is falling apart. Here is what they found, translated into everyday terms:

1. The "Rebel" Residents (Pathogenic Keratinocytes)

In a healthy city, residents follow a clear path. But in HS, the researchers found a specific group of residents who have gone rogue. They call them "Migratory S100+ Keratinocytes."

• The Metaphor: Imagine a group of apartment dwellers who suddenly decide to stop living in their apartments. Instead, they pack up their bags, grab a pickaxe, and start digging tunnels into the basement (the dermis). They are hyper-active, stressed, and constantly shouting for help (inflammation).
• The Finding: These "rebel" cells are found deep inside the tunnels of HS lesions. They aren't just normal skin cells; they have been reprogrammed to act like invaders, creating the painful tunnels that define severe HS.

2. The Two Different Construction Crews (Fibroblast Niches)

The researchers discovered that the "construction crews" (fibroblasts) in the dermis aren't all the same. In fact, they have split into two distinct teams, each helping a different part of the chaos:

• Team A: The "Tunnel Enablers" (COL6A5+ Fibroblasts)

  • The Metaphor: These are the construction crews that hang out right next to the "rebel" residents. Instead of stopping the digging, they seem to be handing the rebels shovels and blueprints. They provide the structural support that allows the skin cells to invade the deeper layers and form those painful tunnels. They are essentially enabling the rebellion.
  • The Finding: These cells are physically close to the undifferentiated, rebellious skin cells and send them chemical signals that encourage them to keep migrating and dividing.

• Team B: The "Fortress Builders" (APOD+ Fibroblasts)

  • The Metaphor: These crews are building a fortress in a different part of the city. They are surrounded by the immune system's heavy artillery (B cells, plasma cells, and T cells). It looks like a Tertiary Lymphoid Organ (TLO)—basically, a mini-army base that has popped up inside the skin because the war has been going on for so long.
  • The Finding: These fibroblasts are the "glue" holding together these immune army bases. They create a safe haven where immune cells can multiply and stay active, keeping the inflammation going even when the initial trigger is gone.

3. The Miscommunication (Why Treatments Fail)

Currently, most treatments for HS are like sending a single police officer to stop a riot. Doctors try to block one specific signal (like turning off the "shouting" of IL-17 or TNF-alpha).

• The Problem: This paper explains why those treatments often only work partially. The city isn't broken in just one place.
  • You have the Rebel Residents digging tunnels, supported by Team A.
  • You have the Immune Army Base being built and maintained by Team B.
  • And there's a Link (Langerhans cells) acting as a bridge between the rebels and the army base, passing messages back and forth.

If you only stop the "shouting" (inflammation), the rebels might stop shouting for a bit, but the construction crews are still there, and the army base is still built. The city remains broken because the entire ecosystem is supporting the disease.

The Big Takeaway

This study suggests that to truly cure HS, we can't just treat the symptoms (the inflammation). We need to fix the whole neighborhood.

We need a strategy that:

1. Stops the Rebel Residents from digging tunnels.
2. Disbands the Construction Crews that are helping them.
3. Dismantles the Immune Army Bases that are keeping the fire burning.

By understanding that HS is a complex dance between skin cells, construction crews, and the immune system, scientists can hope to design better "city plans" (therapies) that address all three groups at once, rather than just trying to silence one part of the noise.

Technical Summary

1. Problem Statement

Hidradenitis Suppurativa (HS) is a chronic, debilitating inflammatory skin disease characterized by painful abscesses, nodules, and sinus tracts (tunnels) in intertriginous areas. Despite its prevalence and significant morbidity, the precise cellular and molecular mechanisms driving severe HS (Hurley stage III) remain poorly understood.

• Current Limitations: Existing therapies targeting single inflammatory pathways (e.g., TNF-α, IL-17) often yield only partial efficacy, suggesting that HS pathogenesis involves complex, multi-compartmental interactions that are not yet fully mapped.
• Knowledge Gap: While genetic studies implicate epidermal differentiation and immune dysregulation, the spatial organization of keratinocytes (specifically pathogenic states), fibroblasts (stromal niches), and immune cells within the HS lesion microenvironment has not been comprehensively characterized at single-cell resolution.

2. Methodology

The authors employed a multi-omics approach combining single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to map the cellular landscape of severe HS.

• Sample Collection: Lesional axillary skin was obtained from three donors with severe HS undergoing wide local excision surgery.
• Single-Cell RNA Sequencing (scRNA-seq):
  • Tissue was enzymatically dissociated, and single-cell suspensions were prepared.
  • 10x Genomics Chromium (3' v3) platform was used to generate transcriptomic data.
  • Analysis: Data was processed using Seurat v5.1 for quality control, normalization, and clustering. Cell types were annotated using canonical marker genes.
  • Trajectory Analysis: Monocle 3 was used to reconstruct lineage trajectories and pseudotime analysis of keratinocyte differentiation.
  • Cell-Cell Communication: CellChat was utilized to infer ligand-receptor interactions and identify dominant signaling pathways between cell populations.
• Spatial Transcriptomics (ST):
  • Fresh-frozen tissue sections were processed using 10x Genomics Visium.
  • Spatial Deconvolution: The cell2location algorithm was used to map the scRNA-seq cell clusters onto the Visium spatial spots, allowing for the prediction of cell type abundance and localization within the tissue architecture.
  • Co-localization: Pearson Correlation Coefficients (PCC) were calculated to assess the spatial association between different cell types.
• Validation: Immunofluorescence staining was performed to validate the presence of specific immune aggregates (B cells, plasma cells, dendritic cells) and their spatial relationship with fibroblasts.

3. Key Contributions

The study defines the HS tissue microenvironment as a complex ecosystem driven by two distinct, spatially segregated niches:

1. Identification of a Pathogenic Keratinocyte State: Discovery of a specific, migratory, S100-expressing keratinocyte state enriched in HS tunnels.
2. Definition of Two Stromal Niches: Characterization of two functionally distinct fibroblast populations that create separate microenvironments: one supporting epithelial remodeling and the other supporting chronic immune activation.
3. Spatial Mapping of TLO-like Structures: Evidence of organized immune aggregates resembling Tertiary Lymphoid Organs (TLOs) in HS, spatially linked to specific fibroblast and vascular subsets.

4. Key Results

A. Pathogenic Keratinocyte States

• Migratory S100+ K/Sebocytes: The authors identified a unique keratinocyte cluster characterized by high expression of S100A7, S100A8, S100A9, and S100A12, alongside genes associated with sebaceous differentiation and HS tunnels.
• Plasticity: Pseudotime analysis revealed that basal keratinocytes can transition into this "Migratory S100+" state, which exhibits high plasticity and is enriched within the epithelialized tunnels of HS lesions.
• Spatial Localization: Spatial mapping confirmed these cells are concentrated within HS tunnels, distinct from the immunobarrier keratinocytes found in the granular layer of normal epidermis.

B. Fibroblast Heterogeneity and Niches

Three distinct fibroblast populations were identified, each with unique spatial distributions and signaling roles:

1. COL6A5+ Papillary Fibroblasts:
   • Location: Preferentially co-localized with undifferentiated keratinocytes (basal, dividing, and transitional remodeling) in the upper dermis and near epithelial structures.
   • Function: High outgoing communication strength. They engage in signaling pathways involving non-canonical Wnt, Activin, and TGF-β, which drive epithelial migration, invasion, and epithelial-mesenchymal transition (EMT).
   • Role: These cells appear to support the physical extension and maintenance of pathogenic keratinocyte tunnels.
2. APOD+ Inflammatory Fibroblasts:
   • Location: Distributed throughout the dermis, specifically co-localizing with vascular endothelial cells, pericytes, and immune aggregates.
   • Function: Associated with extracellular matrix and growth signaling (Collagen, FGF, IGF).
   • Role: They form the stromal scaffold for immune niches.
3. SFRP4+ Reticular Fibroblasts:
   • Location: Deeper dermal areas.
   • Function: Co-localized with macrophages and mast cells but showed weak interaction with keratinocytes.

C. Immune Niches and Tertiary Lymphoid Organ (TLO)-like Structures

• Activated B/Plasma Cells: HS lesions showed a significant abundance of activated B cells (high AICDA expression) and plasma cells.
• Spatial Organization: These immune cells formed dense aggregates containing T cells, dendritic cells, and antigen-presenting cells.
• APOD+ Connection: APOD+ fibroblasts showed the strongest spatial correlation with these plasma/B cell aggregates, suggesting they provide the niche for these TLO-like structures.
• Langerhans Cells: Identified as a critical interface, co-localizing with both the pathogenic COL6A5+ niche (epithelial remodeling) and the APOD+ niche (immune activation), potentially linking early epithelial changes to chronic inflammation.

D. Signaling Networks

• Fibroblast-Keratinocyte Crosstalk: The strongest predicted interactions were between fibroblasts and keratinocytes. COL6A5+ fibroblasts act as primary senders to pathogenic keratinocytes.
• Immune Signaling: Immune cells (Langerhans, T, B, Macrophages) formed a distinct communication pattern (Pattern 3) enriched for TNF, IL-1, and TGF-β, but plasma cells acted more as indirect contributors (via antibodies) rather than direct signaling hubs.

5. Significance and Implications

• Mechanistic Insight: The study proposes a model where HS is not merely an immune disorder but a coordinated failure of epithelial-stromal-immune crosstalk. The disease is sustained by two parallel processes: (1) Fibroblast-driven epithelial remodeling (COL6A5+ niche) and (2) Fibroblast-supported chronic immune activation (APOD+ niche).
• Therapeutic Implications: The limited efficacy of current monotherapies (targeting single cytokines) is explained by the existence of these distinct, spatially segregated niches. Effective treatment may require dual-targeting strategies that address both the epithelial-stromal remodeling (to stop tunnel formation) and the stromal-immune niches (to resolve chronic inflammation).
• Biomarker Potential: The identification of specific fibroblast subtypes (COL6A5+, APOD+) and the S100+ keratinocyte state offers new potential biomarkers for disease stratification and therapeutic monitoring.

In conclusion, this paper provides a high-resolution map of the HS microenvironment, revealing that the disease is driven by specific, spatially organized interactions between pathogenic keratinocytes and distinct fibroblast subsets, challenging the view of HS as a purely immune-mediated condition.